Pregabalin Capsule
Product Images NDC 71335-1790

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-1790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351790)

Label (Lbl713351790)
This appears to be a packaging label for a medication called "Lyrica 50mg (CV)" in capsule form, manufactured by Hetero Labs Limited. The label includes information such as the package date and instructions for storage at room temperature. It also contains a unique NDC (National Drug Code) number for identifying the medication. The label warns to keep the medication out of reach of children.*
FDA Label Image

Label (Lbl7133517902)

Label (Lbl7133517902)
This is a description of Pregabalin Capsules. It contains 30 capsules with each capsule consisting of 50mg Pregabalin USP. The drug is only available through prescription and it should be kept away from the reach of children. It should be stored at a temperature of 20° to 25° C and can be permitted to a range of 15° to 30° C. The NDC number for the drug is 71335-1790-01.*
FDA Label Image
FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

Pregabalinfigure9 (Pregabalinfigure9)
This chart shows the percentage of improvement in pain from baseline for patients taking different doses of Pregabalin and placebo. The chart indicates that patients taking Pregabalin experienced a higher percentage of improvement in pain compared to those taking the placebo. The highest improvement was noted in patients taking Pregabalin 600mg daily dose.*
FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.